Faycal Mouaffak on Muck Rack

Faycal Mouaffak

As seen in: Nature, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Faycal

Contact Faycal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study - Molecular Psychiatry

|
By Ada Ho, Brandon J Coombes, Anthony Batzler, Vanessa Pazdernik, Richard S. Pendegraft, Michelle Skime, Narjes Bendjemaa, Bernardo Carpiniello, Martina Contu, Nina Dalkner, Frederike T Fellendorf, Giovanna Fico, Claudio Fullerton, Manuel Gardea-Resendez, Sarai Gonzalez-Garza, Nematollah Jaafari, Esther Pinilla Jiménez Verified, Oussama Kebir, Adrien Legrand, Sofia Luna-Garza, Anna Meloni, Bruno Millet, Faycal Mouaffak, Abraham J. Nunes, Claire E. O’Donovan, Pasquale Paribello, Marco Pinna, Claudia Pisanu, Edith Pomarol-Clotet, Francisco Romo-Nava, Raul Sanchez, Katie Scott, Alessio Squassina, Elisabet Vilella, Alessandro Serretti, Miguel Prieto, Eva Z Reininghaus, Susanne A. Bengesser, Alfredo Cuellar-Barboza, Marie-Odile Krebs, Boris Chaumette, Eduard Vieta, Mirko Manchia, Susan L. McElroy, Martin Alda, Mark Frye, Joanna M. Biernacka
| Nature Verified
Abstract Identifying biological and clinical factors associated with response to mood-stabilizing medications is critical for improving bipolar disorder (BD) treatment. The Mood Stabilizer Genomics (MoStGen) Consortium was established to investigate pharmacogenomic and clinical predictors of response to treatment of BD with antiepileptic drug mood stabilizers (AMS).
Open in Who Shared Issue with article?

Frontiers | The effects of a group-based intervention through physical activities and dietary changes in young patients with severe psychiatric disorders: a pilot study

|
By Roberta Forte, Faycal Mouaffak, Antonia Kaltsatou
| Frontiers
Introduction People with moderate to severe mental illness have higher rates of somatic comorbidities and premature mortality than the general population (1, 2). Factors such as individual vulnerability, an unhealthy lifestyle, a poor diet, a lack of exercise, and sedentary behavior (3, 4), in addition to the use of new atypical antipsychotics as first-line therapy (5, 6), may lead to the rapid onset of weight gain (7).
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified